Metagenomi Therapeutics MGX
NASDAQ MGX
$1.07 -0.06 (-5.31%)
As of: Sep 30, 2026 · 3:58 PM EDT

Metagenomi Therapeutics (MGX) Other financing activities (2025 - 2026)

Updated

Metagenomi Therapeutics' Other financing activities came in at $7,000 for Q2 2026, down 97.5% from $275,000 a year earlier and down 74.1% from the prior quarter.

Analysis

Metagenomi Therapeutics (MGX) Other financing activities (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Metagenomi Therapeutics reported Other financing activities of $240,000; for FY2025, it came in at $558,000.

  • Business Quant data shows MGX's Other financing activities at $27,000 (Q1 2026), $19,000 (Q4 2025) and $187,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Metagenomi Therapeutics 42.69 Mn 42.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 27,000.00
Dec 31, 2025 19,000.00
Sep 30, 2025 187,000.00
Jun 30, 2025 275,000.00
Mar 31, 2025 77,000.00
API Access

Metagenomi Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=MGX&period=max&api_key=YOUR_API_KEY